Free Trial

Balyasny Asset Management L.P. Trims Stock Position in Healthcare Realty Trust Incorporated (NYSE:HR)

Healthcare Realty Trust logo with Finance background

Balyasny Asset Management L.P. lowered its position in Healthcare Realty Trust Incorporated (NYSE:HR - Free Report) by 64.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 373,893 shares of the real estate investment trust's stock after selling 672,818 shares during the quarter. Balyasny Asset Management L.P. owned approximately 0.11% of Healthcare Realty Trust worth $6,337,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the company. Norges Bank bought a new position in Healthcare Realty Trust during the 4th quarter worth about $76,825,000. Lasalle Investment Management Securities LLC purchased a new position in Healthcare Realty Trust during the fourth quarter valued at approximately $31,398,000. Northern Trust Corp raised its stake in Healthcare Realty Trust by 40.3% in the fourth quarter. Northern Trust Corp now owns 4,040,969 shares of the real estate investment trust's stock worth $68,494,000 after buying an additional 1,159,763 shares in the last quarter. Candriam S.C.A. lifted its holdings in Healthcare Realty Trust by 201.4% during the fourth quarter. Candriam S.C.A. now owns 1,729,651 shares of the real estate investment trust's stock worth $29,318,000 after buying an additional 1,155,745 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. boosted its position in Healthcare Realty Trust by 289.5% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,552,109 shares of the real estate investment trust's stock valued at $26,308,000 after acquiring an additional 1,153,657 shares in the last quarter.

Healthcare Realty Trust Stock Performance

Shares of HR stock opened at $15.36 on Friday. Healthcare Realty Trust Incorporated has a fifty-two week low of $14.53 and a fifty-two week high of $18.90. The firm has a market capitalization of $5.39 billion, a PE ratio of -8.63 and a beta of 0.92. The stock's 50-day simple moving average is $16.03 and its 200-day simple moving average is $16.74.

Healthcare Realty Trust (NYSE:HR - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The real estate investment trust reported $0.39 EPS for the quarter, meeting the consensus estimate of $0.39. Healthcare Realty Trust had a negative net margin of 51.60% and a negative return on equity of 11.20%. The business had revenue of $288.86 million during the quarter, compared to analysts' expectations of $297.39 million. During the same period in the previous year, the business posted $0.39 EPS. The business's quarterly revenue was down 9.2% compared to the same quarter last year. Sell-side analysts forecast that Healthcare Realty Trust Incorporated will post 1.59 earnings per share for the current year.

Healthcare Realty Trust Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 23rd. Investors of record on Monday, May 12th will be given a dividend of $0.31 per share. This represents a $1.24 annualized dividend and a yield of 8.07%. The ex-dividend date is Monday, May 12th. Healthcare Realty Trust's dividend payout ratio is currently -113.76%.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the company. Scotiabank decreased their price objective on Healthcare Realty Trust from $18.00 to $17.00 and set a "sector perform" rating for the company in a research note on Tuesday, February 25th. StockNews.com upgraded shares of Healthcare Realty Trust from a "sell" rating to a "hold" rating in a research note on Thursday. Wedbush reduced their price target on Healthcare Realty Trust from $18.00 to $16.00 and set a "neutral" rating on the stock in a research report on Monday, May 5th. Finally, Wells Fargo & Company reduced their target price on Healthcare Realty Trust from $17.00 to $16.00 and set an "underweight" rating on the stock in a research report on Monday, March 10th. One research analyst has rated the stock with a sell rating and five have assigned a hold rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $17.00.

Get Our Latest Stock Analysis on HR

Healthcare Realty Trust Company Profile

(Free Report)

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.

Recommended Stories

Institutional Ownership by Quarter for Healthcare Realty Trust (NYSE:HR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Healthcare Realty Trust Right Now?

Before you consider Healthcare Realty Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthcare Realty Trust wasn't on the list.

While Healthcare Realty Trust currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Insider Stock Buys in April—Are They Still Good in May?
5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines